Contact
16 Oct 24
News
16 Oct 24
Biocomposites invests in InfectoTest GmbH – developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI)

InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose PJI in less than five minutes

It is based on InfectoTest’s ability to detect the infection in tiny quantities of synovial fluid using a unique method of electrochemical analysis

The investment signifies Biocomposites’ ongoing commitment to providing products for the management of infection in bone…...
Visit us at AAHKS

to discover how STIMULAN® and NanoBone®
can make a difference in your cases
November 8-9
Booth #1409
Gaylord Texan Resort & Convention Center
Grapevine, Texas

18 Sep 24
News
18 Sep 24
Biocomposites acquires remaining shares in manufacturers of SYNICEM™ and Subiton products
SYNICEM™ and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers support surgeons’ infection treatment strategies

Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. are the manufacturers of SYNICEM™ and Subiton products

Keele, UK, 18 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and…...
12 Sep 24
News
12 Sep 24
Biocomposites to distribute its NanoBone® product range in the UK
• NanoBone® is a next-generation osteoinductive bone graft consisting of patented nanostructured hydroxyapatite for remodelling bone
• Biocomposites to introduce NanoBone at the British Orthopaedic Association’s Annual Congress in Birmingham
Keele, UK, 12 September 2024 – Biocomposites, an international medical devices company that engineers, manufactures and…...
Introducing STIMULAN® to
Podiatrists and Tissue Viability Nurses

Diabetic foot osteomyelitis and diabetic foot ulcers
can be challenging to heal. Find out how STIMULAN can help.

Your specialty

Access case studies, clinical and pre-clinical papers for musculoskeletal infection, trauma and spine to see how we are innovating across a wide range of clinical applications to help surgeons and their patients.

Musculoskeletal infections

Musculoskeletal infections, including infected non-unions, osteomyelitis and periprosthetic joint infections, are one of the biggest healthcare challenges of the 21st century.

As the rapid growth of antibiotic-resistant strains and biofilms continues to outpace the development of new antibiotics and antibiotic strategies, care delivery is becoming increasingly challenging and complicated.

Spine

The popularity of spine surgery differs around the world. The number of procedures performed in the USA is double the number performed in Western Europe, Canada and Australia combined, and five times the number in the UK.

In the USA, the number of spinal fusion procedures increased by 64% between 2002 and 2014, from approximately 268,000 to 414,000. The average cost per procedure has increased from $15,868 to $28,954 over the same period and was more than $12 billion in total in 2014.

Why Biocomposites?

Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue.

Based in Keele, UK, it has global operations across Europe, South America, USA, Canada, China and India.

Learn more